D Planas, D Veyer, A Baidaliuk, I Staropoli… - Biorxiv, 2021 - biorxiv.org
Abstract The SARS-CoV-2 B. 1.617 lineage emerged in October 2020 in India–. It has since then become dominant in some indian regions and further spread to many countries. The …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B. 1.1. 7 and B. 1.351 variants were first identified in the United Kingdom and South Africa, respectively, and have …
P Arora, A Kempf, I Nehlmeier, L Graichen… - Cellular & molecular …, 2021 - nature.com
The emergence of SARS-CoV-2 variants threatens efforts to control the COVID-19 pandemic. At present, the global spread of the Delta (B. 1.617. 2) variant is responsible for a …
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuing to evolve around the world, generating new variants that are of concern on the basis of their potential …
Abstract The B. 1.617. 2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in the state of Maharashtra in late 2020 and spread …
Abstract The B. 1.1. 529/Omicron variant of SARS-CoV-2 was only recently detected in southern Africa, but its subsequent spread has been extensive, both regionally and globally …
The COVID-19 pandemic has had widespread effects across the globe, and its causative agent, SARS-CoV-2, continues to spread. Effective interventions need to be developed to …
A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant, BA. 2.86, has emerged and spread to numerous countries worldwide, raising alarm because its …
D Ho, P Wang, L Liu, S Iketani, Y Luo, Y Guo, M Wang… - 2021 - europepmc.org
The Covid-19 pandemic has ravaged the globe, and its causative agent, SARS-CoV-2, continues to rage. Prospects of ending this pandemic rest on the development of effective …